TY - JOUR
T1 - Characteristics of endogenous γ-aminobutyric acid (GABA) in human platelets
T2 - Functional studies of a novel collagen glycoprotein VI inhibitor
AU - Lin, Kuan Hung
AU - Lu, Wan-Jung
AU - Wang, Shwu Huey
AU - Fong, Tsorng Harn
AU - Chou, Duen Suey
AU - Chang, Chao Chien
AU - Chang, Nen Chung
AU - Chiang, Yung Chen
AU - Huang, Shih Yi
AU - Sheu, Joen Rong
N1 - Funding Information:
Acknowledgments We wish to thank Prof. Tur-Fu Huang in the Department of Pharmacology (College of Medicine, National Taiwan University) for providing convulxin and aggretin for our experiments. This work was supported by grants from the National Science Council, Taiwan (NSC97-2320-B-038-016-MY3, NSC100-2320-B-038-021-MY3, NSC102-2320-B-341-001-MY3, and NSC102-2811-B-038-026), Taipei Medical University Hospital (100 TMU-TMUH-03), Shin Kong Wu Ho-Su Memorial Hospital (SKH-8302-102-NDR-04 and SKH-8302-103-NDR-05), and Cathay General Hospital (100CGH-TMU-12).
PY - 2014/6
Y1 - 2014/6
N2 - gamma-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the central nervous system, and it also appears in peripheral tissues. Platelets are anuclear blood cells that play a central role in hemostatic processes. Although platelets possess a GABA uptake system, the functional activity of GABA in platelets has remained unclear. We determined that GABA is abundantly distributed in the platelets at a concentration of approximately 1.03 ng/10 6 cells. GABA (0.5 μM) specifically inhibited collagen-induced platelet activation accompanied by [Ca2+]i mobilization, phospholipase Cγ2, protein kinase C, Akt phosphorylation, and hydroxyl radical formation. In addition, GABA interfered with fluorescein isothiocyanate-collagen binding to platelet membranes and produced a concentration-dependent shift in the collagen concentration-response curve and a Schild plot slope of -0.96±0.11, indicating competitive inhibition. Platelet activation induced by convulxin, a glycoprotein VI agonist, was inhibited by GABA, whereas activation induced by the integrin α2β1 agonist, aggretin, was not. Immunoprecipitation and surface plasmon resonance revealed that GABA binds directly to glycoprotein VI in human platelets with equilibrium dissociation (binding) constant (K D) of 41.4 nM. The closure time of whole blood and the occlusion time of platelet plug formation were significantly prolonged by GABA in vivo. In this study, GABA is a specific inhibitor of collagen glycoprotein VI and may be involved in an endogenous negative feedback mechanism for platelet activation. Thus, GABA may represent a potential target for the development of novel interventions for the treatment of cardiovascular diseases associated with platelet activation, such as stroke and myocardial infarction. Key messages: GABA is abundantly distributed in the platelets. GABA inhibited platelet activation stimulated by convulxin. GABA directly associated with glycoprotein VI in platelet membrane. GABA prolonged the closure time of whole blood and the occlusion time of platelet plug formation in vivo.
AB - gamma-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the central nervous system, and it also appears in peripheral tissues. Platelets are anuclear blood cells that play a central role in hemostatic processes. Although platelets possess a GABA uptake system, the functional activity of GABA in platelets has remained unclear. We determined that GABA is abundantly distributed in the platelets at a concentration of approximately 1.03 ng/10 6 cells. GABA (0.5 μM) specifically inhibited collagen-induced platelet activation accompanied by [Ca2+]i mobilization, phospholipase Cγ2, protein kinase C, Akt phosphorylation, and hydroxyl radical formation. In addition, GABA interfered with fluorescein isothiocyanate-collagen binding to platelet membranes and produced a concentration-dependent shift in the collagen concentration-response curve and a Schild plot slope of -0.96±0.11, indicating competitive inhibition. Platelet activation induced by convulxin, a glycoprotein VI agonist, was inhibited by GABA, whereas activation induced by the integrin α2β1 agonist, aggretin, was not. Immunoprecipitation and surface plasmon resonance revealed that GABA binds directly to glycoprotein VI in human platelets with equilibrium dissociation (binding) constant (K D) of 41.4 nM. The closure time of whole blood and the occlusion time of platelet plug formation were significantly prolonged by GABA in vivo. In this study, GABA is a specific inhibitor of collagen glycoprotein VI and may be involved in an endogenous negative feedback mechanism for platelet activation. Thus, GABA may represent a potential target for the development of novel interventions for the treatment of cardiovascular diseases associated with platelet activation, such as stroke and myocardial infarction. Key messages: GABA is abundantly distributed in the platelets. GABA inhibited platelet activation stimulated by convulxin. GABA directly associated with glycoprotein VI in platelet membrane. GABA prolonged the closure time of whole blood and the occlusion time of platelet plug formation in vivo.
KW - Collagen
KW - Convulxin
KW - Glycoprotein VI antagonist
KW - Platelet activation
KW - γ-Aminobutyric acid
UR - http://www.scopus.com/inward/record.url?scp=84901607763&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84901607763&partnerID=8YFLogxK
U2 - 10.1007/s00109-014-1140-7
DO - 10.1007/s00109-014-1140-7
M3 - Review article
C2 - 24626935
AN - SCOPUS:84901607763
SN - 0946-2716
VL - 92
SP - 603
EP - 614
JO - Journal of Molecular Medicine
JF - Journal of Molecular Medicine
IS - 6
ER -